핵의학

본문글자크기
  • [Cancers (Basel).] Optimization of Predictive Performance for the Therapeutic Response Using Iodine Scan-Corrected Serum Thyroglobulin in Patients with Differentiated Thyroid Carcinoma.

    [Cancers (Basel).] Optimization of Predictive Performance for the Therapeutic Response Using Iodine Scan-Corrected Serum Thyroglobulin in Patients with Differentiated Thyroid Carcinoma.

    전남의대 / 유수웅, Md. Sunny Anam Chowdhury, 권성영*

  • 출처
    Cancers (Basel).
  • 등재일
    2020 Jan 22
  • 저널이슈번호
    12(2). pii: E262. doi: 10.3390/cancers12020262.
  • 내용

    바로가기  >

    Abstract
    We investigated whether the performance of serum thyroglobulin (Tg) for response prediction could be improved based on the iodine uptake pattern on the post-therapeutic I-131 whole body scan (RxWBS) and the degree of thyroid tissue damage with radioactive iodine (RAI) therapy. A total of 319 patients with differentiated thyroid carcinoma who underwent total thyroidectomy and RAI therapy were included. Based on the presence/absence of focal uptake at the anterior midline of the neck above the thyroidectomy bed on RxWBS, patients were classified into positive and negative uptake groups. Serum Tg was measured immediately before (D0Tg) and 7 days after RAI therapy (D7Tg). Patients were further categorized into favorable and unfavorable Tg groups based on the prediction of excellent response (ER) using scan-corrected Tg developed through the stepwise combination of D0Tg with ratio Tg (D7Tg/D0Tg). We investigated whether the predictive performance for ER improved with the application of scan-corrected Tg compared to the single Tg cutoff. The combined approach using scan-corrected Tg showed better predictive performance for ER than the single cutoff of D0Tg alone (p < 0.001). Therefore, scan-corrected Tg can be a promising biomarker to predict the therapeutic responses after RAI therapy.

     


    Author information

    Yoo SW1, Chowdhury MSA1,2, Jeon S1, Kang SR1, Cho SG3, Kim J3, Lee C1,4, Ryu YJ5, Song HC3,4, Bom HS1,4, Min JJ1,4, Kwon SY1,4.
    1
    Department of Nuclear Medicine, Chonnam National University Hwasun Hospital, Jeollanam-do 58128, Korea.
    2
    Institute of Nuclear Medicine and Allied Sciences, Bangladesh Atomic Energy Commission, Bogra 5800, Bangladesh.
    3
    Department of Nuclear Medicine, Chonnam National University Hospital, Gwangju 61469, Korea.
    4
    Department of Nuclear Medicine, Chonnam National University Medical School, Jeollanam-do 58128, Korea.
    5
    Department of Surgery, Chonnam National University Hwasun Hospital, Jeollanam-do 58128, Korea.

  • 키워드
    differentiated thyroid carcinoma; iodine scan; therapeutic response; thyroglobulin
  • 연구소개
    Thyroglobulin (Tg)은 갑상선분화암에서 치료반응을 평가하거나 예후를 예측하는 대표적인 생화학적 표지자이지만 방사성요오드 치료 효과를 정밀하게 반영하지 못하는 단점도 가지고 있습니다. 해당 연구에서는 방사성요오드 치료 전후 Tg의 변화정도와 방사성요오드 치료 후 스캔 소견을 단계별로 조합하여 scan-corrected Tg라는 새로운 표지자를 도출하였습니다. 이 표지자와 기존에 사용되고 있는 치료 전 Tg를 비교하였을 때 새로운 표지자에서 치료반응을 예측하는 정확도가 유의하게 향상되었습니다. 이러한 표지자가 향후 방사성요오드 치료효과를 보다 정확히 평가하는 데 도움이 될 것으로 기대합니다.
  • 편집위원

    갑상선암에서 방사성요오드 치료 후 Excellent response 군에 포함되는 환자의 예후는 매우 좋은 것으로 알려져, 이러한 환자를 예측하는 것은 임상에 도움이 됨. 위 임상연구는 방사성요오드 스캔을 보정한 Tg 값을 이용하면 단순한 Tg값을 이용한 것에 비하여 Excellent response 군을 더욱 정확히 선별할 수 있을 가능성을 보여 줌. 갑상선암 관련 임상가와 핵의학 전문가에게 관심을 끌 논문으로 생각됨.

    2020-03-02 16:39:54

  • 덧글달기
    덧글달기
       IP : 3.145.186.173

    등록